Article
Using pegylated interferon alfa-2b and ribavirin to treat chronic hepatitis patients infected with hepatitis c virus genotype 1: are nonresponders and relapsers different populations?
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases - 1 Dec 2007
Silva Giovanni Faria, Polônio Rodrigo José, Pardini Maria Inês Moura Campos, Corvino Silvia Maria, Henriques Rita Maria Saccomano, Peres Mari Nilce, Silveira Liciana Vaz Arruda, Coelho Kunie Iabuki Rabello
Abstract excerpt
The combination of pegylated interferon (PEG-INF) and ribavirin is currently the best treatment for chronic hepatitis C, providing a sustained virological response (SVR) in 54%-63% of patients. In patients infected with hepatitis C virus (HCV) genotype 1, the SVR rate is 42%-52%. To evaluate the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.